Genprex Share Based Compensation vs Net Cash Flow or Change in Cash and Cash Equivalents Analysis

GNPX Stock

USD 2.35 0.33 12.31%

Trend analysis of Genprex balance sheet accounts such as Total Current Liabilities of 3.4 M or Total Stockholder Equity of 14.2 M provides information on Genprex's total assets, liabilities, and equity, which is the actual value of Genprex to its prevalent stockholders. By breaking down trends over time using Genprex balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Total Assets Net Tangible Assets

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genprex. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.

About Genprex Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Genprex at a specified time, usually calculated after every quarter, six months, or one year. Genprex Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Genprex and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Genprex currently owns. An asset can also be divided into two categories, current and non-current.

Genprex Balance Sheet Chart

Genprex Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Genprex uses and utilizes its capital. It also shows what exactly a company owns and owes.

At this time, Genprex's Liabilities And Stockholders Equity is fairly stable compared to the past year. Capital Surpluse is likely to rise to about 107.8 M in 2024, whereas Property Plant And Equipment Net is likely to drop 7,466 in 2024.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Genprex assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Genprex books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Genprex balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Genprex are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most indicators from Genprex's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genprex current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genprex. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.At this time, Genprex's Issuance Of Capital Stock is fairly stable compared to the past year. Enterprise Value is likely to rise to about 8.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 9.2 M in 2024.

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	22.5K	25.6K	17.7K	17.4K
Interest Income	5.1K	90.1K	231.0K	242.6K

Reconciled Depreciation Interest Income

Genprex fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Net Receivables
Total Assets		0.43	0.5	1.0	0.78	0.75	-0.99	-0.62	0.46	1.0	0.74	0.68	0.14	1.0	0.79	-0.74	0.8	0.65	0.81	0.5	0.7	1.0	0.77	0.88	0.72	-0.03
Other Current Liab	0.43		0.96	0.38	0.82	0.1	-0.33	-0.88	0.76	0.39	0.79	0.85	-0.01	0.39	0.78	-0.61	0.77	0.82	0.76	0.96	0.66	0.38	0.75	0.32	0.73	0.33
Total Current Liabilities	0.5	0.96		0.45	0.9	0.19	-0.38	-0.96	0.89	0.45	0.83	0.9	-0.09	0.45	0.87	-0.72	0.86	0.93	0.82	1.0	0.77	0.45	0.81	0.29	0.84	0.08
Total Stockholder Equity	1.0	0.38	0.45		0.74	0.76	-0.99	-0.58	0.42	1.0	0.69	0.64	0.15	1.0	0.76	-0.71	0.76	0.62	0.77	0.45	0.67	1.0	0.73	0.88	0.68	-0.05
Net Tangible Assets	0.78	0.82	0.9	0.74		0.41	-0.69	-0.97	0.82	0.75	0.85	0.88	-0.04	0.75	0.97	-0.83	0.98	0.97	0.93	0.9	0.84	0.75	0.89	0.52	0.9	-0.05
Property Plant And Equipment Net	0.75	0.1	0.19	0.76	0.41		-0.77	-0.35	0.27	0.75	0.45	0.31	0.19	0.75	0.57	-0.7	0.55	0.37	0.57	0.19	0.72	0.76	0.66	0.84	0.65	-0.18
Net Debt	-0.99	-0.33	-0.38	-0.99	-0.69	-0.77		0.52	-0.35	-0.99	-0.69	-0.61	-0.15	-0.99	-0.71	0.66	-0.71	-0.55	-0.75	-0.38	-0.62	-0.99	-0.71	-0.9	-0.63	0.0
Retained Earnings	-0.62	-0.88	-0.96	-0.58	-0.97	-0.35	0.52		-0.88	-0.58	-0.82	-0.87	0.09	-0.58	-0.95	0.84	-0.95	-0.98	-0.91	-0.96	-0.87	-0.58	-0.9	-0.4	-0.93	0.05
Accounts Payable	0.46	0.76	0.89	0.42	0.82	0.27	-0.35	-0.88		0.43	0.73	0.81	0.02	0.43	0.82	-0.68	0.81	0.89	0.72	0.89	0.76	0.42	0.75	0.18	0.82	-0.31
Cash	1.0	0.39	0.45	1.0	0.75	0.75	-0.99	-0.58	0.43		0.71	0.65	0.13	1.0	0.76	-0.7	0.76	0.62	0.77	0.45	0.67	1.0	0.73	0.87	0.68	-0.03
Non Current Assets Total	0.74	0.79	0.83	0.69	0.85	0.45	-0.69	-0.82	0.73	0.71		0.96	-0.07	0.71	0.81	-0.72	0.8	0.77	0.91	0.83	0.7	0.69	0.85	0.62	0.77	0.19
Non Currrent Assets Other	0.68	0.85	0.9	0.64	0.88	0.31	-0.61	-0.87	0.81	0.65	0.96		-0.13	0.65	0.82	-0.69	0.81	0.83	0.84	0.9	0.68	0.63	0.77	0.49	0.77	0.15
Other Assets	0.14	-0.01	-0.09	0.15	-0.04	0.19	-0.15	0.09	0.02	0.13	-0.07	-0.13		0.13	0.13	-0.04	0.05	-0.08	0.0	-0.09	0.04	0.16	0.1	0.28	-0.02	-0.12
Cash And Short Term Investments	1.0	0.39	0.45	1.0	0.75	0.75	-0.99	-0.58	0.43	1.0	0.71	0.65	0.13		0.76	-0.7	0.76	0.62	0.77	0.45	0.67	1.0	0.73	0.87	0.68	-0.03
Common Stock Total Equity	0.79	0.78	0.87	0.76	0.97	0.57	-0.71	-0.95	0.82	0.76	0.81	0.82	0.13	0.76		-0.9	1.0	0.95	0.93	0.87	0.93	0.77	0.95	0.61	0.96	-0.11
Common Stock Shares Outstanding	-0.74	-0.61	-0.72	-0.71	-0.83	-0.7	0.66	0.84	-0.68	-0.7	-0.72	-0.69	-0.04	-0.7	-0.9		-0.9	-0.82	-0.86	-0.72	-0.94	-0.72	-0.91	-0.65	-0.94	0.15
Capital Surpluse	0.8	0.77	0.86	0.76	0.98	0.55	-0.71	-0.95	0.81	0.76	0.8	0.81	0.05	0.76	1.0	-0.9		0.96	0.94	0.86	0.93	0.77	0.94	0.59	0.96	-0.12
Other Current Assets	0.65	0.82	0.93	0.62	0.97	0.37	-0.55	-0.98	0.89	0.62	0.77	0.83	-0.08	0.62	0.95	-0.82	0.96		0.88	0.93	0.88	0.62	0.87	0.38	0.92	-0.17
Other Stockholder Equity	0.81	0.76	0.82	0.77	0.93	0.57	-0.75	-0.91	0.72	0.77	0.91	0.84	0.0	0.77	0.93	-0.86	0.94	0.88		0.82	0.86	0.77	0.97	0.67	0.9	0.03
Total Liab	0.5	0.96	1.0	0.45	0.9	0.19	-0.38	-0.96	0.89	0.45	0.83	0.9	-0.09	0.45	0.87	-0.72	0.86	0.93	0.82		0.77	0.45	0.81	0.29	0.84	0.08
Property Plant And Equipment Gross	0.7	0.66	0.77	0.67	0.84	0.72	-0.62	-0.87	0.76	0.67	0.7	0.68	0.04	0.67	0.93	-0.94	0.93	0.88	0.86	0.77		0.68	0.94	0.6	0.99	-0.17
Total Current Assets	1.0	0.38	0.45	1.0	0.75	0.76	-0.99	-0.58	0.42	1.0	0.69	0.63	0.16	1.0	0.77	-0.72	0.77	0.62	0.77	0.45	0.68		0.74	0.88	0.69	-0.05
Intangible Assets	0.77	0.75	0.81	0.73	0.89	0.66	-0.71	-0.9	0.75	0.73	0.85	0.77	0.1	0.73	0.95	-0.91	0.94	0.87	0.97	0.81	0.94	0.74		0.68	0.95	-0.03
Common Stock	0.88	0.32	0.29	0.88	0.52	0.84	-0.9	-0.4	0.18	0.87	0.62	0.49	0.28	0.87	0.61	-0.65	0.59	0.38	0.67	0.29	0.6	0.88	0.68		0.58	0.25
Property Plant Equipment	0.72	0.73	0.84	0.68	0.9	0.65	-0.63	-0.93	0.82	0.68	0.77	0.77	-0.02	0.68	0.96	-0.94	0.96	0.92	0.9	0.84	0.99	0.69	0.95	0.58		-0.14
Net Receivables	-0.03	0.33	0.08	-0.05	-0.05	-0.18	0.0	0.05	-0.31	-0.03	0.19	0.15	-0.12	-0.03	-0.11	0.15	-0.12	-0.17	0.03	0.08	-0.17	-0.05	-0.03	0.25	-0.14

Click cells to compare fundamentals

Genprex Account Relationship Matchups

Genprex fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.5M	31.4M	42.9M	25.1M	10.7M	15.4M
Other Current Liab	74.4K	257.8K	612.1K	2.4M	1.9M	1.9M
Total Current Liabilities	510.7K	450.7K	1.6M	2.8M	3.3M	3.4M
Total Stockholder Equity	3.0M	30.9M	41.3M	22.3M	7.4M	14.2M
Net Tangible Assets	8.5M	2.5M	30.3M	40.6M	46.7M	49.1M
Property Plant And Equipment Net	44.7K	39.4K	48.6K	23.0K	7.9K	7.5K
Net Debt	(2.0M)	(27.3M)	(38.6M)	(21.0M)	(6.7M)	(7.1M)
Retained Earnings	(40.5M)	(58.4M)	(78.0M)	(102.8M)	(133.7M)	(127.0M)
Accounts Payable	436.3K	193.0K	973.2K	442.9K	1.4M	1.5M
Cash	2.0M	27.3M	38.6M	21.0M	6.7M	13.0M
Non Current Assets Total	557.6K	651.8K	3.7M	3.6M	3.1M	1.7M
Non Currrent Assets Other	21.7K	10.7K	3.0M	2.9M	2.4M	2.5M
Other Assets	21.7K	612.4K	0.0	1.0	0.9	0.86
Cash And Short Term Investments	2.0M	27.3M	38.6M	21.0M	6.7M	13.0M
Common Stock Total Equity	11.7K	15.2K	19.3K	43.1K	49.6K	52.1K
Common Stock Shares Outstanding	400.7K	888.1K	1.2M	1.2M	1.4M	1.3M
Liabilities And Stockholders Equity	3.5M	31.4M	42.9M	25.1M	10.7M	15.4M
Capital Surpluse	17.9M	38.7M	43.5M	89.3M	102.7M	107.8M
Other Current Assets	171.7K	384.6K	511.3K	484.2K	794.1K	833.8K
Other Stockholder Equity	43.5M	89.3M	119.2M	125.1M	141.1M	73.4M
Total Liab	510.7K	450.7K	1.6M	2.8M	3.3M	3.4M
Property Plant And Equipment Gross	7.8K	24.4K	44.7K	39.4K	45.4K	47.6K
Total Current Assets	3.0M	30.7M	39.1M	21.5M	7.5M	13.8M
Intangible Assets	491.2K	601.6K	642.4K	702.1K	773.5K	523.9K
Common Stock	19.3K	43.1K	47.9K	48.1K	1.5K	1.4K
Property Plant Equipment	24.4K	44.7K	39.4K	48.6K	55.9K	58.7K
Net Receivables	8.8K	9.3K	655.0	127.0	0.0	34.9K
Net Invested Capital	3.0M	30.9M	41.3M	22.3M	7.4M	7.0M
Net Working Capital	2.5M	30.3M	37.6M	18.7M	4.3M	4.1M
Capital Stock	19.3K	43.1K	47.9K	48.1K	1.5K	1.4K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Genprex offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genprex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genprex Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genprex Stock:

How To Invest In Genprex

Details

Is Genprex Stock a good investment?

Details

What is Genprex's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.

You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Genprex Stock analysis

When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.

	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.

Is Genprex's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genprex. If investors know Genprex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genprex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(22.56)

Return On Assets

(1.09)

Return On Equity

(2.08)

The market value of Genprex is measured differently than its book value, which is the value of Genprex that is recorded on the company's balance sheet. Investors also form their own opinion of Genprex's value that differs from its market value or its book value, called intrinsic value, which is Genprex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genprex's market value can be influenced by many factors that don't directly affect Genprex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Genprex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genprex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genprex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Genprex Share Based Compensation vs Net Cash Flow or Change in Cash and Cash Equivalents Analysis

About Genprex Balance Sheet Analysis

Genprex Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Genprex fundamental ratios Correlations

Genprex Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Genprex fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Genprex Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Cash	+ 1.0	Total Stockholder Equity

Total Current Assets	- 0.99	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity
Net Debt	- 0.99	Total Assets
Other Current Assets	- 0.98	Retained Earnings